In this Axios column, Drew Altman shows that unlike the individual market, narrow networks are not common in the much larger group market, and discusses why and why it matters.
- view as grid
- view as list
n this Axios column, Drew Altman presents a puzzle around corporate health costs: companies are talking like there is a crisis, but new data doesn’t really show it.
In this Axios column, Drew Altman discusses why surprise medical bills could be a powerful campaign issue.
A Comparative Analysis of Affected Residents’ Views of the Response to Hurricanes Maria, Harvey and Katrina
Drew Altman compares residents’ views of hurricane-recovery efforts based on five surveys of residents affected by Hurricanes Maria, Harvey and Katrina.
The number of uninsured is down. Health spending has moderated. But health is on the public’s mind. Drew Altman helps explain why in this Axios column.
In this Axios column, Drew Altman says health care is a bigger factor for Democrats now than it was for Republicans in recent elections, and could be as big a factor for Democrats and independents as Donald Trump is in the midterms.
In this Axios column, Drew Altman examines the potential implications of the Kentucky Medicaid waiver case for other states and future waivers.
In a Health Affairs blog post, Laurie Sobel, Caroline Rosenzweig and Alina Salganicoff of the Kaiser Family Foundation discuss the feasibility of abortion riders to private group and individual health plans as a means of providing access to abortion coverage when states ban the coverage as part of an insurance plan.…
In this June 2018 post for The JAMA Forum, Larry Levitt examines the potential impact of the Trump Administration’s legal challenge to the Affordable Care Act’s protections for people with pre-existing conditions.
In an Axios column, Drew Altman analyzes the narrowing gap between growth in health spending and GDP and discusses why it matters. The big question, he says, is will the narrowing have staying power?